Semax vs Cerebrolysin

Overview

This comparison separates Semax and Cerebrolysin for reference—not product selection.

Semax: Chemically stabilised Semax variant. Marketed as an improvement, but studied far less than Semax itself.

Cerebrolysin: Peptide preparation derived from pig brain tissue, used clinically in some countries for stroke and dementia.

Differences

• Both appear in Cognitive & neurological research literature, but mechanistic framing differs.
• The useful distinction is research question and receptor context—not relative potency or practical ranking.

Mechanism

Semax: Acetylation and amidation are standard medicinal chemistry techniques for protecting a peptide's exposed ends from the enzymes that trim peptides from either te…

Cerebrolysin: The preparation is described as having neurotrophic activity — mimicking the effect of the body's own nerve growth factors on neuron survival and repair.

Pharmacology

Semax: Pharmacokinetic detail should be read from primary literature.

Cerebrolysin: Pharmacokinetic detail should be read from primary literature.

Research

Semax: Cognitive & neurological research: Rapid improvement in sustained attention, working memory, and mental clarity within 15-30 minutes.

Cerebrolysin: Cognitive & neurological research: Meta-analyses show modest cognitive improvements, though clinical significance remains debated.

Summary

Distinction

• AXIOM does not provide dosing, administration, or protocol guidance.
• Catalogue links appear only where AXIOM lists a research-use product.
• Reference-only compounds remain comparison terms without implying availability.

References

• pubmed.ncbi.nlm.nih.gov/29798983/
• pubmed.ncbi.nlm.nih.gov/30225715/
• pubmed.ncbi.nlm.nih.gov/24661604/
• pubmed.ncbi.nlm.nih.gov/16996037/
• pubmed.ncbi.nlm.nih.gov/9173745/
• pubmed.ncbi.nlm.nih.gov/29248999/
• pubmed.ncbi.nlm.nih.gov/36979317/
• pubmed.ncbi.nlm.nih.gov/28458521/

Questions